NSGC recommends expanded carrier screening be available as option for all who are currently pregnant, considering pregnancy, or might biologically contribute to pregnancy
New data highlight favorable outcomes tied to pharmacogenomic (PGx) testing in depression, and expert opinions evolve regarding utility
This webinar examined disparities and barriers to mental health care and discussed successful efforts organizations have made to counter these dynamics. The role pharmacogenetic testing may have in improving medication selection and health outcomes for individuals suffering from mental health conditions, such as depression, was also covered.
Featured speakers included:
Gwendolyn Turner, MSL, Sr Dir DEI Engagement
Devki Nagar, MS, CGC, Dir Managed Care